Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study
Takumi Sakurada(Tokushima University Hospital), Keisuke Ishizawa(Tokushima University Hospital), Yoshito Zamami(Tokushima University Hospital), Mitsuhiro Goda(Okayama University), Akira Tangoku, Masayuki Chuma(Nihon University), Sanako Bando(Tokushima University Hospital), Toshimi Nakamura(Tokushima University Hospital), Kazuhiko Teraoka(Tokushima University Hospital), Yasushi Kirino(Tokushima University Hospital), Masami Morimoto(Tokushima University), Kenshi Takechi(Matsuyama University)
Cited by 3
Related Papers
Thoracic and cardiovascular surgeries in Japan during 2017
|General Thoracic and Cardiovascular Surgery|2020|164
Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis
|JAMA Oncology|2019|134
Thoracic and cardiovascular surgeries in Japan during 2018
|General Thoracic and Cardiovascular Surgery|2020|123